Continuing Medical Education Enhances Clinicians’ Knowledge of Homozygous Familial Hypercholesterolemia
Early treatment of homozygous familial hypercholesterolemia (HoFH) improves outcomes for children and reduces the risk of progressive atherosclerotic cardiovascular disease. Unfortunately, the disease often goes undetected until it is in the advanced stages. Read More
What Medical Education Reveals about Barriers to Adoption of Biologic Agents for Moderate-to-Severe Asthma
For people with moderate-to-severe asthma, personalization of biologic agents is warranted based on factors such as biomarkers and comorbidities. PlatformQ Health and the Asthma and Allergy Foundation of America (AAFA) conducted a CME-certified, case based, expert panel discussion that featured a live Q&A session with leading faculty from the Asthma Center at Cincinnati Children's Hospital Medical Center and the Division of Allergy and Immunology at Northwestern University's Feinberg School of Medicine, as well as AAFA's public health manager. Read More
Lessons Learned by Tracking Educational Program Outcomes
PlatformQ Health is known for its outcomes-driven education. At this year’s European Conference on Rare Diseases, we co-presented two posters highlighting outcomes and lessons learned from recent programming. Read More
Understanding the Impact of CME on Participant Knowledge and Behavior
The first FDA-approved gene therapy for pediatric patients with Duchenne muscular dystrophy (DMD) is now available. This is a genetic disorder that presents as progressive muscle degeneration and weakness. Read More
Partnership Pulse
As we look forward to the holiday season, we are filled with gratitude to all our incredible partners. Read More
Program Outcomes Demonstrate Dire Need for FOP Education
PlatformQ Health, the National Organization for Rare Disorders (NORD), the International Fibrodyslpasia Ossificans Progressiva Association (IFOPA) Read More
Health Equity Drives Extension of Exclusive Alliance Between PlatformQ Health and the Asthma and Allergy Foundation of America
The Asthma and Allergy Foundation of America (AAFA) and PlatformQ Health have extended their long-standing collaboration for another three years to continue bringing trusted digital education to those affected by asthma and related conditions. Read More
Fall 2023 Partnership Pulse
As we look forward to the holiday season, we are filled with gratitude to all our incredible partners. Read More
Uncovered Barriers to Clinical Trial Enrollment Among Patients with Non-Hodgkin’s Lymphoma
Clinical trials are crucial for advancing care for non-Hodgkin's lymphoma (NHL), however, accrual in these studies remains low. To address this issue, PlatformQ Health, the Leukemia & Lymphoma Society, BlackDoctor.org, and Partners for Advancing Clinical Education co-produced the BUILD-NHL Trial Equity Initiative. Read More
Driving Equitable Healthcare through Patient and Provider Education
PlatformQ Health, the Asthma and Allergy Foundation of America (AAFA), and BlackDoctor.org were seeking to understand whether aligned (sequential patient/provider) education could help improve health equity for those suffering from conditions such as asthma and atopic dermatitis. Read More
Unexamined Ways to Drive Clinical Trial Enrollment
Clinical trial recruitment has been a persistent problem, with studies showing up to 55% of trials are canceled prematurely due to low enrollment rates. These rates are even more dismal when it comes to diverse populations, including ethnic and racial minorities as well as seniors. Common methods for improving trial access such as transportation supports have been well documented, yet there are numerous other avenues for improving the patient experience that have yet to be uncovered. Read More
Program Outcomes Demonstrate High Need for Immunotherapy Education
Immunotherapy is increasingly being used to treat patients with melanoma and other types of cancer. Management of these therapies differs distinctly from previous standard-of-care options such as chemotherapy. Optimizing care involves educating a multidisciplinary healthcare team about therapy management as well as educating patients about therapies and the factors that can influence outcomes. Read More
